FREMONT, Calif.--(BUSINESS WIRE)--Zosano Pharma, Inc., a privately held pharmaceutical company developing products based on its novel transdermal delivery technology, today announced that Thorsten von Stein, MD, PhD has joined the company as Chief Medical Officer. Dr. von Stein reports to Zosano Chair and CEO, Gail Schulze.
